Guerbet Aktie

19,46EUR -8,39EUR -30,13%
Guerbet für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 870481 / ISIN: FR0000032526

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 2 635 2 730 2 839 2 920 2 905
Umsatz pro Mitarbeiter in Mio. EUR 0,27 0,27 0,27 0,27 0,29

Bilanz (in Mio. EUR) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 469 495 510 582 590
Summe Anlagevermögen 477 505 430 444 447
Summe Aktiva 946 1 001 940 1 025 1 037

Bilanz (in Mio. EUR) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 581 596 560 647 646
Summe Eigenkapital 364 405 380 378 392
Summe Passiva 946 1 001 940 1 025 1 037

Adresse

15, rue des Vanesses, 93420 Paris
Telefon +33 (1) 45-91-50-00
Internet http://www.guerbet.com

Management

Carine Dagommer
Director
Charlotte Bamière
Senior Vice President-Compliance & General Counsel
Claire Massiot-Jouault
Non-Independent Director
Céline Lamort
Non-Independent Director
Dan Raffi
Director-Commercial Operations
David Hale
Chief Executive Officer
Didier Izabel
Independent Director
Eric Guerbet
Director
Eva Ohlsson
Senior Vice President-Human Resources
François Nicolas
Chief Digital Officer, Senior Vice President-R&D
Jean-Hugues Louis Lecat
Chairman
Jean-Sébastien Raynaud
Director
Jérôme Estampes
CFO, Senior VP-Business Development & Licensing
Marc Massiot
Director
Marie de la Simone
Director
Mark Fouquet
Non-Independent Director
Nicolas Louvet
Non-Independent Director
Pascale Auger
Independent Director
Philippe Bourrinet
SVP-Development, Medical & Regulatory Affairs
Raoul Bernhardt
Director-Industrial Operations
Valérie Brissart
Senior Vice President Marketing-Diagnostic Imaging